The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Effect of increased body mass index on time to tumor progression in metastatic unresectable colorectal cancer patients treated with bevacizumab-based therapy.
Ibrahim Yildiz
No relevant relationships to disclose
Fatma Sen
No relevant relationships to disclose
Leyla Kilic
No relevant relationships to disclose
Serkan Keskin
No relevant relationships to disclose
Rumeysa Ciftci
No relevant relationships to disclose
Meltem Ekenel
No relevant relationships to disclose
Nuri Faruk Aykan
No relevant relationships to disclose